Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma

Mult Scler. 2015 Apr;21(5):670. doi: 10.1177/1352458514549403. Epub 2014 Sep 25.

Authors

Edward J Gettings¹, Christopher T Hackett¹, Thomas F Scott²

Affiliations

¹ Department of Neurology, Allegheny General Hospital, Pittsburgh, USA.
² Department of Neurology, Allegheny General Hospital, Pittsburgh, USA Drexel University College of Medicine, Philadelphia, USA tscott@wpahs.org.

PMID: 25257614
DOI: 10.1177/1352458514549403

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal / therapeutic use
Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use
Ataxia / etiology
Gait Disorders, Neurologic / etiology
Humans
Ipilimumab
Male
Melanoma / complications*
Melanoma / drug therapy
Middle Aged
Multiple Sclerosis, Relapsing-Remitting / complications*
Paresis / etiology
Recurrence
Treatment Outcome

Substances

Antibodies, Monoclonal
Antineoplastic Agents
Ipilimumab